Alessandra Bisi
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 37
- Synthesis of Organic Compounds 18
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents 14
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods 29
- Organic Chemistry top 1%
- Synthesis and biological activity 16
- Chemical synthesis and alkaloids 13
- Molecular Medicine top 5%
-
- Estrogen and related hormone effects 18
-
- Alzheimer's disease research and treatments 16
Alessandra Bisi
117 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 1.6k
- Toxicology 231
- Computational Theory and Mathematics 1.0k
- Organic Chemistry 1.5k
- Molecular Medicine 110
Countries citing papers authored by Alessandra Bisi
This map shows the geographic impact of Alessandra Bisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bisi more than expected).
Fields of papers citing papers by Alessandra Bisi
This network shows the impact of papers produced by Alessandra Bisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bisi. The network helps show where Alessandra Bisi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandra Bisi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 12 | |
| 7 | 2020 | 20 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 19 | |
| 10 | 2018 | 61 | |
| 11 | 2018 | 20 | |
| 12 | 2017 | 70 | |
| 13 | 2014 | 20 | |
| 14 | 2011 | 34 | |
| 15 | 2008 | 13 | |
| 16 | 2006 | 10 | |
| 17 | 2005 | 35 | |
| 18 | 2003 | 29 | |
| 19 | 2000 | 84 | |
| 20 | 4-Heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect | 1991 | 2 |
About Alessandra Bisi
Alessandra Bisi is a scholar working on Toxicology, Pharmacology and Computational Theory and Mathematics, having authored 120 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (37 papers), Computational Drug Discovery Methods (29 papers), Estrogen and related hormone effects (18 papers), Synthesis of Organic Compounds (18 papers), Synthesis and biological activity (16 papers), Alzheimer's disease research and treatments (16 papers), Bioactive Compounds and Antitumor Agents (14 papers) and Chemical synthesis and alkaloids (13 papers). The work is most often cited by research in Pharmacology (1.6k citations), Toxicology (231 citations) and Computational Theory and Mathematics (1.0k citations). Alessandra Bisi has collaborated with scholars based in Italy, Germany and Spain. Frequent co-authors include Angela Rampa, Silvia Gobbi, Federica Belluti, Vincenza Andrisano, Andrea Cavalli, Maurizio Recanatini, Manuela Bartolini, Piero Valenti, Lorna Piazzi and Rolf W. Hartmann. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Molecules, Bioorganic & Medicinal Chemistry and Current Topics in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.